Multiple system atrophy (MSA) is a rare, fatal, neurodegenerative disease of the adulthood presenting with progressive autonomic failure, parkinsonian, cerebellar and pyramidal features in various combinations.

Research Fellowship winners 2020   It is a great pleasure to introduce the recipients of the Research Fellowship  2020 (in alphabetical order): Research Training Fellowship:  Marianthi Breza from Greece was selected for her project: “On the TRAIL of neurodegeneration: a… Continue Reading

Autonomic nervous system (ANS) disorders are common and may cause severe disease burdon on patients. The ANS controls all inner organs and the skin. Malfunction of this important part of the nervous system might often cause transient loss of consciousness, heart rate and blood pressure instability, sweat gland dysfunction, gastrointestinal symptoms, sexual dysfunction, and many others. It is of utmost importance to diagnose autonomic disorders to be able to offer specific treatment recommendations.

On November 14-15 2019, the Advanced Deep Brain Stimulation for Movement Disorders course of the International Parkinson and Movement Disorders Society was organized in the Haga Teaching Hospital in The Hague (The Netherlands). Movement disorder neurologists, functional neurosurgeons, nurse practitioners, and trainees from all over the world came to visit the political capital of the Netherlands.

The Societal Impact of Pain (SIP) has organized a workshop "Health data standardisation workshop: looking at the implementation of ICD-11 and ICF" on November 6th 2019. More than 60 scientific experts, decisions makers and patients' representatives gathered at the Permanent Representation of the Federal Republic of Germany to the European Union in Brussels.

The 2019 Biomedical Alliance in Europe General Assembly took place on 20 November in our offices in Brussels. We were happy to see so many of you there to exchange views on activities, policy developments and potential directions for the future.

Every month, you will find an original self-portrait of one Scientific Committee member, who will respond informally to the same 5 questions. Here we go!

College of EC Commissioners approved by the European Parliament

Why is ean your home of neurology?

Lemtrada for multiple sclerosis: measures to minimise risk of serious side effects

You can find further details on the Clinical Fellowship page on the EAN website.

25 November: Mark the dates for the 30th Alzheimer Europe Conference 2020!

Launch Alzheimer's Disease (AD) Detect and Prevent Newsletter

Positive outcome of the open letter adding “research” to the title of the Commissioner Designate Mariya Gabriel

Brain health back on the agenda in the European Parliament. Research policy still pending.